Medin Technologies said last week it tapped Bill Donaldson as its new chief executive officer, replacing Andy Novotny who is resigning from his position at the head of the company.
Prior to joining Medin Technologies, Donaldson served as president of Jeld-Wen Canada, leading the business unit during its parent company’s initial public offering, Totowa, N.J.-based Medin Technologies said.
Donaldson has also held positions with Circor’s KF Industries, Sagebrush Pipeline, Spence Engineering and Danaher’s Kollmorgen.
“I cannot imagine a more important and exciting time to join Medin Technologies. With an outstanding set of world-class customers who are demanding more and more of the company, Medin is well-positioned to grow and diversify its product offering. This is the perfect opportunity for me to combine my operating experience with my passion for working with customers. I look forward to working with this great team and leading Medin Technologies through its next exciting phase of growth,” Donaldson said in a prepared statement.
Novotny, who saw Medin Technologies through its acquisition by Seven Point Equity Partners, will stay on to assist with the transition, Medin said.
“We are thrilled to have Bill join us as CEO and as a member of the board. He brings outstanding leadership qualities, deep manufacturing experience, and a passion for delivering exceptional value to customers. Medin is growing quickly, and we are absolutely confident Bill is the right leader to maximize the company’s market opportunity in medical contract manufacturing and at the same time build on the company’s existing reputation for world-class quality and customer responsiveness,” Seven Point managing partner and Medin board member Tom Burchill said in a prepared release.
“Our medical device and orthopedic implant OEM customers have extremely high quality, design, and delivery expectations, and we believe Bill, with his strong track record of operational excellence, will enhance these already strong capabilities,” Seven Point partner and Medin board member Mark Kammert said in a press release.
Ra Medical said late last week it named Andrew Jackson as its CFO, effective immediately.
Immediately prior to joining Carlsbad, Calif.-based Ra Medical, Jackson served as chief financial officer at AltheaDx. Before joining AltheaDx, Jackson held CFO positions at Celladon Corp., Ra Medical said.
“Andrew is a perfect fit for Ra Medical, as he brings his broad financial experience in the life sciences industry to our rapidly growing team. His proven leadership and deep expertise will strengthen our company moving forward,” CEO Dean Irwin said in a prepared statement.
“I’m eager to hit the ground running and join Ra Medical at such an exciting time in the company’s lifecycle, especially given the recent FDA market clearance of our DABRA System as a treatment for peripheral artery disease. I’m delighted to join this dynamic team and hope to be a key asset to the Company’s strategic and financial initiatives,” Jackson said in a press release.
Prior to joining the Fort Worth, Texas-based company, McNeil served as controller for Smith & Nephew‘s (NYSE:SNN) US advanced wound management division, holding the position from between 2012 and 2018.
McNeil has also held positions with Healthpoint Biotherapeutics, Burlington Resources, Snyder Oil Corporation and Union Pacific, Wound Management Tech said.
The company added that Bodner will replace former principal accounting officer John Gallagher, who has moved to a different position within the company.
Bodner had operated as BD’s medical segment CFO since 2013, and international CFO since 2017, the Franklin Lakes, N.J.-based company said.
Both terminations were the “result of a streamlining of operating functions as part of the company’s ongoing efforts to reduce expenses,” the Lexington, Mass.-based company said.
GI Dynamics said that just before the terminations, it lifted former finance director and general accounting manager Dave Bruce to the position of principal accounting and financing officer.